What Makes Bio-Techne Corporation (TECH) an Investment Bet?
Polen Capital, an investment management company, released its “Polen U.S. SMID Company Growth Strategy” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Bio-Techne Corp (TECH)
Market is closed
News
- First
- << Previous
- 11 - 20
- Next >>
Bio-Techne Corporation (NASDAQ:TECH) Q2 2024 Earnings Call Transcript
Bio-Techne Corporation misses on earnings expectations. Reported EPS is $0.4 EPS, expectations were $0.42.
Should You Hold Bio-Techne Corporation (TECH) For the Long Term?
Fred Alger Management, an investment management company, released its “Alger Small Cap Growth Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Bio-Techne Corporation (NASDAQ:TECH) Q1 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2024.
Various Headwinds Pressured Bio-Techne Corporation (TECH) Shares in Q3
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2023 investor letter. A copy of the same can be downloaded here.
Bio-Techne Corporation (NASDAQ:TECH) Q4 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Fourth Quarter of Fiscal Year 2023.
Should You Hold Bio-Techne Corp. (TECH)?
Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here.
Bio-Techne Corporation (NASDAQ:TECH) Q3 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Bio-Techne Corp Third Quarter Fiscal 2023 Earnings Call. All participants will be in a listen-only mode. Please note today’s event is being recorded.
Here’s Why Bio-Techne Corporation (TECH) Declined in Q1
Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Bio-Techne Corporation (NASDAQ:TECH) Q2 2023 Earnings Call Transcript
Operator: Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2023.
- First
- << Previous
- 11 - 20
- Next >>
Billionaire Hedge Funds
